According to Invitae 's latest financial reports the company's current earnings (TTM) are -$1.46 B. In 2022 the company made an earning of -$3.16 B a decrease over its 2021 earnings that were of -$0.42 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$1.46 B | -53.86% |
2022 | -$3.16 B | 657.75% |
2021 | -$0.42 B | -41.78% |
2020 | -$0.72 B | 174.28% |
2019 | -$0.27 B | 97.05% |
2018 | -$0.14 B | 5.52% |
2017 | -$0.13 B | 24.92% |
2016 | -$0.11 B | 11.67% |
2015 | -$89.79 M | 89.05% |
2014 | -$47.5 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Celldex Therapeutics CLDX | -$0.15 B | -90.23% | ๐บ๐ธ USA |
HTG Molecular Diagnostics
HTGM | -$19.53 M | -98.66% | ๐บ๐ธ USA |
CareDx CDNA | -$0.11 B | -92.80% | ๐บ๐ธ USA |